Mounjaro, the brand name for tirzepatide, is a drug that treats type 2 diabetes by lowering blood sugar levels. According to ...

The FDA, in a stark reversal, on Friday said it would reconsider its decision to remove Eli Lilly’s tirzepatide, from its ...

The change will expand access to the diabetes and weight-loss drugs. But it will also complicate the future of compounded ...

Now that Mounjaro has been authorised for use on the NHS, it will be key that access to specialist weight loss services is ...

The FDA updated its database of drugs in shortage to remove tirzepatide, which had sat on that list – along with related ...

Unlike Ozempic, Wegovy is approved for weight management even though they both contain semaglutide. However, they do have ...

A trade organization representing compounding pharmacies that make unbranded versions of the weight loss drugs Mounjaro and ...

NICE has opened a consultation on the possible mass rollout of tirzepatide to millions of people in England over the next decade.

Eli Lilly's weight-loss drug Zepbound and diabetes medication Mounjaro are no longer in short supply. That could limit ...

After nearly two years, federal regulators announced the shortage of the active ingredient in Mounjaro and Zepbound has been ...

On October 2, 2024, the U.S. Food and Drug Administration (FDA) determined the shortage of the tirzepatide injection, a glucagon-like peptide ...